Systematic comparison of the statistical operating characteristics of various Phase I oncology designs
Dose finding Phase I oncology designs can be broadly categorized as rule based, such as the 3 + 3 and the accelerated titration designs, or model based, such as the CRM and Eff-Tox designs. This paper systematically reviews and compares through simulations several statistical operating characteristi...
Main Authors: | Revathi Ananthakrishnan, Stephanie Green, Mark Chang, Gheorghe Doros, Joseph Massaro, Michael LaValley |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865416300461 |
Similar Items
-
On the designs of early phase oncology studies
by: Ananthakrishnan, Revathi Nayantara
Published: (2018) -
Advanced Designs of Cancer Phase I and Phase II Clinical Trials
by: Cui, Ye
Published: (2013) -
Challenges in implementing model-based phase I designs in a grant-funded clinical trials unit
by: Eleni Frangou, et al.
Published: (2017-12-01) -
Acoustic Performance-Based Design: A Brief Overview of the Opportunities and Limits in Current Practice
by: Elena Badino, et al.
Published: (2020-05-01) -
A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method
by: Bernard North, et al.
Published: (2019-06-01)